Medtronic Wins 10th Circ. Battle Against Infuse Injury Suit
The Tenth Circuit on Tuesday rejected a plaintiff's arguments that her injury claims over Medtronic Inc.'s Infuse bone graft device are not preempted because they involved off-label uses not approved by...To view the full article, register now.
Already a subscriber? Click here to view full article